News

The sNDA approval was based on results of a double-blind, randomised, placebo-controlled, two-arm, parallel-group study which enrolled 54 adults with EPI due to CP or pancreatectomy. The primary

ReGen Therapeutics said that in in-vitro studies Colostrinin has been shown to prevent the aggregation of beta-amyloid and reduce it’s toxicity to cells. Colostrinin has also been shown

Doxorubicin is a drug which is used in chemotherapy for the treatment of leukemias, lymphomas and other cancers. Encapsulation of Doxorubicin in Siosomes is designed to increase efficacy

The data were presented at the Digestive Disease Week (DDW) 2010 conference in New Orleans, Louisiana, as part of the distinguished abstract plenary session. Sucampo Pharmaceuticals said that

Results were statistically significant and showed that azilsartan medoxomil (80 mg/day) lowered 24-hour SBP by ambulatory blood pressure monitoring (ABPM), the primary endpoint, in head-to-head trials with the

The licensing agreement between Spring Creek Capital and McCoy Enterprise, LLC/Vectoris Pharma, gives Spring Creek the exclusive rights to produce, market, distribute and sell products based on method

Singapore’s integrated research network offers multidisciplinary capabilities across basic and translational research. Biopolis is a biomedical research hub in Singapore that co-locates public-sector institutes and private-sector corporate labs.

The data presented demonstrate that statistical significance versus placebo was achieved for the primary endpoint of 12-week complete spontaneous bowel movement (CSBM) overall responder for each of the

McKesson has posted a net income of $348m for the fourth quarter of 2010, or $1.26 per diluted share, compared to $281m, or $1.01 per diluted share, for